Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
November 19, 2020
We don’t know as much as we should about the real-world costs and effectiveness of climate mitigation projects in low- and middle-income countries. This blog looks at what we do know and finds that real-world cost-effectiveness appears to be orders-of-magnitude different between projects even in the...
Blog Post
November 18, 2020
Since the beginning of the outbreak, the scientific community has worked around the clock to produce evidence to support decision-makers in all aspects of COVID management. However, health economics research has been largely missing from this growing literature. The C19economics.org platform has bee...
Blog Post
November 09, 2020
This morning, America (and much of the world) woke up to a snippet of terrific news: Pfizer and BioNTech announced their SARS-CoV2 vaccine candidate showed 90 percent efficacy. But for policymakers in low- and middle-income countries, today’s news offers limited cause for celebration—and the Pfizer/...
Blog Post
October 28, 2020
COVID- 19 has brought a sense of urgency to decision-making that typically would have taken many months and years of deliberation. Central to this uncertainty is the glaring lack of knowledge on just how big the burden of COVID-19 truly is. The pandemic has highlighted concerning gaps in data and we...
POLICY PAPERS
October 27, 2020
Is research into a Covid-19 vaccine a suitable use of Official Development Assistance (ODA)? This note attempts to tease apart a discussion of “is this ODA” from “is this a global public good?” and then separate out again “is this ODA and/or a global public good?” from “is this an efficient way...